Journal Article

SMN2 splicing modifiers improve motor function and longevity in mice with spinal muscular atrophy

Chen, Guangming, Colacino, Joseph M., Babiak, John, Furia, Bansri, Lee, Chang-Sun, Gerlach, Irene, Santarelli, Luca, Weetall, Marla, Eng, Loren A., Welch, Ellen M., Ling, Karen K. Y., Dakka, Amal, Ghosh, Anirvan, Naryshkin, Nikolai A., McCarthy, Kathleen D., Lynes, Maureen S., Qi, Hongyan, Ma, Jiyuan, Feng, Zhihua, Zhang, Nanjing, Haehnke, Daniel, Zhang, Xiaoyan, Ko, Chien-Ping, Metzger, Friedrich, Trifillis, Panayiota, Zhao, Xin, Woll, Matthew G., Sheedy, Josephine, Karp, Gary M., Mull, Jesse L., Rubin, Lee L., Gabbeta, Vijayalakshmi, Moon, Young-Choon, Risher, Nicole, Vazirani, Priya, Fontoura, Paulo, Ebeling, Martin, Almstead, Neil G., Bhattacharyya, Anuradha, Sivaramakrishnan, Manaswini, Chen, Karen S., Peltz, Stuart W., Schmucki, Roland, Paushkin, Sergey V., Narasimhan, Jana, Kong, Ronald, Turpoff, Anthony, Ratni, Hasane

2014

Overview

Spinal muscular atrophy (SMA) is a genetic disease caused by mutation or deletion of the survival of motor neuron 1 (SMN1) gene. A paralogous gene in humans, SMN2, produces low, insufficient levels of functional SMN protein due to alternative splicing that truncates the transcript. The decreased levels of SMN protein lead to progressive neuromuscular degeneration and high rates of mortality. Through chemical screening and optimization, we identified orally available small molecules that shift the balance of SMN2 splicing toward the production of full-length SMN2 messenger RNA with high selectivity. Administration of these compounds to Δ7 mice, a model of severe SMA, led to an increase in SMN protein levels, improvement of motor function, and protection of the neuromuscular circuit. These compounds also extended the life span of the mice. Selective SMN2 splicing modifiers may have therapeutic potential for patients with SMA.

• Publisher: American Association for the Advancement of Science,The American Association for the Advancement of Science
• Subject: Anatomy / animal disease models / Atrophy / Cell membranes / Drugs / Exons / Fibroblasts / Genes / Genetic disorders / longevity / Messenger RNA / Mice / Molecules / motor neurons / muscle fibers / Muscles / muscular atrophy / Muscular system / Narcotics / Nervous system / Neurons / Patients / Proteins / RNA / RNA splicing / Signal transduction / Spinal cord / Splicing